DNA Methylation Biomarkers to Predict Survival After Surgery for Lung Adenocarcinoma

Clinical trial NCT06477211 · COMPLETED

Trial details

NCT number: NCT06477211
Sponsor: Nanjing University
Status: COMPLETED
Study type: OBSERVATIONAL

Lung Adenocarcinoma Surgery Prognostic Cancer Model

Start date: 2024-02-01
Primary completion: 2024-12-20
Enrollment: 292

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.